1. Тареев Е.М. Коллагенозы. М., 1965.
2. Payan HM, EF Gilbert. Granulomatosis Coronary Arteritis. Arch Pathol Lab Med 1984; 108: 136–7.
3. Kay RH, Poley R, Herman MV. Unsuspected Giant Cell Arteritis Diagnosed at Open Surgery. Arch Intern Med 1982; 142: 1378–9.
4. Albert C. Cuetter. Exracephalic Manifestaions Of Giant Cell Arteritis. Am J Med 1991; 90: 536.
5. Семенкова Е.Н. Трудности диагностики коронарита при системных васкулитах. Тер. архив. 1994; 66: 50–4.
6. Paulley JW. Coronary ischemia and occulusion in giant cell (temporal) arteritis. Acta Med Scand 1980; 208: 257–63.
7. Endo M, Tomizawa Y, Nishida H et al. Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 2003; 125: 570–7.
8. Arima M, Kanoh T, Kawano Y et al. Isolated Coronary ostial stenosis associated with coronary vasospasm. Jap Circulation J 2000; 64: 985–7.
9. Tejada AO, Torres GS, Alfaro JK. Cardiac damage in Takayasu's arteritis. Study in 125 patients. Arch Inst Cardiol Mex 1983; 53 (5): 441–7.
10. Johnston SL, Rock RJ, Gompels MM. Takayasu arteritis: a review. J Сlini Pathol 2002; 55 (7): 481–6.
11. Sebnem KS, Bostan O, Сil E .Takayasu arteritis. Ann Rheum Dis 2002; 61: 92–3.
12. Schrader M, Hochman J, Bulkley B. The heart in poltarteritis nodosa: A clinicopathologic study. Am Heart J 1985; 109: 1353–9.
13. Rajani RM, Dalvi BV, D'Silva SA et al. Acute myocardial infarction with normal coronary arteries in a case of polyarteritis nodosa: possible role of coronary artery spasm. Postgrad Medi J 1991; 67: 78–80.
14. Somer T. Thrombo-embolic and vascular complications in vasculitis syndromes. Eur Heart J 1993; 14: 24–9.
15. Клименко О.В., Семенкова Е.Н., Кривошеев О.Г. Особенности клинического течения, прогностические факторы и исходы узелкового полиартериита. Гепатологический форум. 2005; 2: 18–21.
16. Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki Disease in the Adult. Tex Heart Inst J 2004; 31: 160–4.
17. Burns JC, Shike H, Gordon JB et al. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28: 253–7.
18. Renaldini E, Spandrio S, Cerudelli B et al. Cardiac involvement in Charge-Strauss syndrome: a follow-up of three cases. Eur Heart J 1993; 14: 112–1.
19. Lanham JG, Churg J. Churg-Strauss syndrome. Systemic vasculitides. Ed. A.Churg, J.Churg. New York: Igaku-Shoin, 1991; 101–20.
20. Lanham JG, Elkon KB, Pusey CD et al. Systemic vasculitis with astma and eosinopholia: a clinical approach to the Churg Strauss syndrome. Medicine (Baltimore) 1984; 63: 65–81.
21. Masi AT, Hunder GG, Lie GT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrom (allergic granulamotosis angiitis). Arthritis Rheum1990; 2: 1094–100.
22. Семенкова Е.Н., Моисеев С.В., Наместникова О.Г. Клинические аспекты синдрома гиперэозинофилии. Клин. мед. 2004; 2: 28–31.
23. Lie JT, Bayardo RJ. Isolated eosinophilic coronary arteritis and eosinophilic myocarditis. A limited form of Churg-Strauss syndrome. Arch Path Lab Med 1989; 2: 199–201.
24. McGavin CR, Marshall AJ, Lewis CT. Churg-Strauss syndrome with critical endomyocardial fibrosis: 10 year survival after combined surgical and medical management. Heart. 2002; 5: 5.
25. Sablе-Fourtassou R, Cohen P, Mahr A et al. French Vasculitis Study Group. Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss. Ann Intern Med 2005; 9: 632–8.
26. Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 9: 2926–35.
27. Korantzopoulos P, Papaioannides D, Siogas K. The Heart in Wegener's Granulomatosis. Cardiology 2004; 102: 7–10.
28. Morelli S, Di Castelmenardo GAM, Conti F et al. Cardiac involvement in patienys with Wegener,s granulomatosis. Rheumatol Int 2000; 19: 209–12.
29. NO Ghaussy, TW Du Clos, PA Ashley. Limited Wegener's granulomatosis presenting with complete heart block. Scand J Rheumatol 2004; 33: 115–8.
30. Forstot JZ, Overlie PA, Neufeld GK et al. Cardiac complications of Wegener granulomatosis: A case report of complete heart block and review of the literature. Semin Arthritis Rheum 1980; 10: 148–54.
31. Fischer M, Baessler A, Hense HW et al. Prevalence of left ventricular diastolic dysfunction in community. Eur Heart J 2003; 24: 320–8.
32. Genereau T, Lortholary O, Guillevin L et al. Temporal 67 gallium uptake is increased in temporal arteritis. Rheumatilogy 1999; 38: 709–13.
33. Терновой С.К., Синицын В.Е., Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М., 2003.
34. Raza K, Thambyrajah J, Townend JN et al. Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular Endothelial Function: Lessons for Atherosclerotic Disease? Circulation 2000; 102: 1470–2.
35. Booth AD, Jayne DRW, Kharbanda RK et al. Wilkinson. Infliximab Improves Endothelial Dysfunction in Systemic Vasculitis A Model of Vascular Inflammation. Circulation 2004; 109: 1718–23.
36. Marz W, Wieland H. HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering? Herz 2000; 25: 1–9.

Л.А.Стрижаков, О.Г.Кривошеев, Е.Н.Семенкова, Е.А.Коган